Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600132-20-000002
Filing Date
2020-01-07
Accepted
2020-01-07 08:22:01
Documents
6
Period of Report
2020-01-07
Effectiveness Date
2020-01-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A blphproxyjanuary2020.htm DEF 14A 231021
2 a035yzbbellerophon02.jpg GRAPHIC 757673
3 a035yzbbellerophon03.jpg GRAPHIC 315431
4 aksignaturea03.jpg GRAPHIC 11536
5 blphlogoa66.jpg GRAPHIC 32979
6 ftsignaturea02.jpg GRAPHIC 13086
  Complete submission text file 0001600132-20-000002.txt   1784593
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

EIN.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36845 | Film No.: 20512149
SIC: 2834 Pharmaceutical Preparations